- Report
- September 2026
- 506 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,441GBP
- Report
- January 2026
- 180 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- September 2026
- 188 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 184 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- February 2026
- 172 Pages
Global
From €4339EUR$4,850USD£3,717GBP
- Report
- August 2022
- 117 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- March 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- July 2026
- 207 Pages
From €7148EUR$7,990USD£6,124GBP
- Report
- June 2024
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- June 2024
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- June 2024
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- June 2024
- 260 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1342EUR$1,500USD£1,150GBP
- Report
- February 2024
- 120 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- June 2025
- 200 Pages
Global
From €2495EUR$2,789USD£2,138GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2495EUR$2,789USD£2,138GBP

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline.
Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more